Blood Cells Molecules and Diseases

Papers
(The median citation count of Blood Cells Molecules and Diseases is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies32
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)29
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)27
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?26
ABO blood groups, COVID-19 infection and mortality26
Effectiveness of convalescent plasma in Indian patients with COVID-1925
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis20
The potential role of emicizumab prophylaxis in severe von Willebrand disease19
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis18
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?16
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study15
MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies15
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis14
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients13
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model13
Hematologically important mutations: Leukocyte adhesion deficiency (second update)12
Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions11
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders11
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria10
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia10
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore10
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature9
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease9
RNF220 promotes the proliferation of leukaemic cells and reduces the degradation of the Cyclin D1 protein through USP229
Platelet-derived microvesicles activate human platelets via intracellular calcium mediated reactive oxygen species release9
High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies9
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia9
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India9
Potential ‘significance’ of monoclonal gammopathy of ‘undetermined significance’ during COVID-19 pandemic8
Prognostic factors associated with COVID-19 related severity in sickle cell disease8
Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia7
Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia7
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis7
Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency7
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort7
A case series highlighting structured hematological, biochemical and molecular approach to clinical oral iron refractoriness in children: A pressing need for a 3-tier system for classification of vari6
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations6
Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes6
Daratumumab as a novel treatment option in refractory ITP6
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency6
Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients6
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort6
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment6
Development of a Thalassemia International Prognostic Scoring System (TIPSS)6
Pediatric bone marrow failure: Clinical, hematological and targeted next generation sequencing data6
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil5
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)5
Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone5
Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome5
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients5
Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect5
VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy5
Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders5
Impact of maternal iron deficiency anemia on fetal iron status and placental iron transporters in human pregnancy5
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity5
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry4
JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment4
Bio-net dataset: AI-based diagnostic solutions using peripheral blood smear images4
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients4
Sickle cell disease mice have cerebral oxidative stress and vascular and white matter abnormalities4
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data4
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects4
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study4
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study4
Hypoferremia of inflammation: Innate host defense against infections4
Age-dependent characterization of carotid and cerebral artery geometries in a transgenic mouse model of sickle cell anemia using ultrasound and microcomputed tomography4
TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia4
Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content4
Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism4
Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III4
New germline GATA1 variant in females with anemia and thrombocytopenia4
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients4
Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels3
Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes3
Inherited disorders of hemoglobin: A review of old and new diagnostic methods3
CXCL15/Lungkine has suppressive activity on proliferation and expansion of multi-potential, erythroid, granulocyte and macrophage progenitors in S-phase specific manner3
Evidence for complement-mediated bone marrow necrosis in a young adult with sickle cell disease3
Stathmin 1 deficiency induces erythro-megakaryocytic defects leading to macrocytic anemia and thrombocythemia in Stathmin 1 knock out mice3
Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease3
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing3
Characterization of peripheral T helper 17 (Th17) cells phenotype in postmenopausal women with estrogen insufficiency3
Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination3
Rasa3 regulates stage-specific cell cycle progression in murine erythropoiesis3
Human cord blood hematopoietic cells acquire neural features when cultured in the presence of neurogenic cytokines2
Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity2
Missense mutation in RPS7 causes Diamond-Blackfan anemia via alteration of erythrocyte metabolism, protein translation and induction of ribosomal stress2
Targeting of Calbindin 1 rescues erythropoiesis in a human model of Diamond Blackfan anemia2
Unveiling mortality risk factors in paediatric sickle cell disease patients during acute crises in the Democratic Republic of the Congo2
A stepwise diagnostic approach for undiagnosed Anemia in children: A model for low-middle income country2
Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement2
Analysis of evolutionary conservation of GPI-anchored proteins between humans and mice2
Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment2
Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors2
Megakaryocyte-specific knockout of the Mir-99b/let7e/125a cluster lowers platelet count without altering platelet function2
Thirty-five males with severe (Class 1) G6PD deficiency (c.637G>T) in a North American family of European ancestry2
Essential genetic modifiers and their measurable impact in a community-recruited population analysis for non-severe hemoglobin E/β-thalassemia prenatal genetic counseling2
Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses2
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL2
Dizygotic twins with prolonged jaundice and microcytic, hypochromic, hemolytic anemia with pyropoikilocytosis2
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?2
Characterisation of a mitochondrial glutamine transporter provides a new opportunity for targeting glutamine metabolism in acute myeloid leukaemia2
LXRβ is involved in the control of platelet production from megakaryocytes2
Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response2
Preclusion of methemoglobinemia caused by nitrate drugs in diabetics and nondiabetics: Possible role of Vitamin C2
Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies?2
Myeloid-derived suppressor cells anticipate sustained treatment response in newly-diagnosed and persistent primary immune thrombocytopenia2
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels2
Red cell anarchy. Evidence of neoplastic dyserythropoiesis2
BAALC gene expression tells a serious patient outcome tale in NPM1-wild type/FLT3-ITD negative cytogenetically normal-acute myeloid leukemia in adults2
Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?2
Heptamer-type small guide RNA that can shift macrophages toward the M1 state2
Up-regulation of microRNA 101-3p during erythropoiesis in β-thalassemia/HbE2
Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity2
First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen1
Artefactual decrease in the fluorescence intensity of hereditary spherocytosis EMA test related to statins1
Systemic corticosteroids in the treatment of warm autoimmune hemolytic anemia: A clinical setting perspective1
Unmasking the morphological alteration of erythrocytes among women suffering from PCOS1
Trpv1 and Trpa1 are not essential for Psickle-like activity in red cells of the SAD mouse model of sickle cell disease1
Pancytopenia and thrombosis defects in zebrafish mutants of Fanconi anemia genes1
Cellular and animal models for the investigation of β-thalassemia1
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent1
Eltrombopag as second line treatment in patients with primary immune thrombocytopenia: A single center real life experience1
CD133+CD34+ cells can give rise to EPCs: A comparative rabbit and human study1
Reliability of different estimated glomerular filtration rate as measures of renal function in children with sickle cell disease1
Influence of initial clinical suspicion on the diagnostic yield of laboratory enzymatic testing in lysosomal storage disorders. Experience from a multispecialty hospital1
Two new mutations in the GLRX5 gene cause sideroblastic anemia1
Plasma exosomal microRNA expression profiles in patients with high-altitude polycythemia1
Investigation of the cytotoxicity, genotoxicity and antioxidant prospects of JM-20 on human blood cells: A multi-target compound with potential therapeutic applications1
Effect of voxelotor on murine bone marrow and peripheral blood with hematopoietic progenitor cell mobilization for gene therapy of sickle cell disease1
Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolism1
Plasma immune mediators as laboratorial biomarkers for Sickle Cell Disease patients according to the hydroxyurea therapy and disease severity1
Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axis1
Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestions1
Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race1
Chronic lymphocytic leukemia with a transient atypical T-cell proliferation raising concern for T-cell lymphoma1
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia1
IFN-γ directly inhibits the activity of erythropoietin in human erythroid progenitors1
Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities1
Stereotyped B-cell receptors in the context of a diverse Brazilian series of chronic lymphocytic leukemia1
Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center s1
Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells1
Understanding increased ferritin levels in pediatric ECMO patients1
0.084376096725464